MAZE Maze Therapeutics, Inc.

NASDAQ

$26.05

Maze Therapeutics, Inc. (MAZE) Earnings News

Earnings press releases, previews and reviews for Maze Therapeutics, Inc. (MAZE), newest first.

Tuesday August 11, 2026 4:01 PM ET

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Tuesday May 12, 2026 4:01 PM ET

Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights